Book contents
- The Well-Woman Visit
- The Well-Woman Visit
- Copyright page
- Contents
- Contributors
- Introduction
- Section 1 General Principles
- Section 2 Components of the Well-Woman Visit
- Introduction – Components of the Well-Woman Visit at Different Life Stages
- Section 2.1 Health Maintenance
- Section 2.2 Cardiovascular Health
- Section 2.3 Metabolic and Nutritional Health
- Section 2.4 Urinary Tract Assessment
- Section 2.5 Contraception and Reproductive Health
- Section 2.6 Infectious Diseases
- Section 2.7 Cancer Screening and Prevention
- Section 2.8 Neurologic, Behavioral, and Psychosocial Health
- Section 2.9 Pregnancy
- Index
- References
Section 2.4 - Urinary Tract Assessment
from Section 2 - Components of the Well-Woman Visit
Published online by Cambridge University Press: 22 June 2017
Book contents
- The Well-Woman Visit
- The Well-Woman Visit
- Copyright page
- Contents
- Contributors
- Introduction
- Section 1 General Principles
- Section 2 Components of the Well-Woman Visit
- Introduction – Components of the Well-Woman Visit at Different Life Stages
- Section 2.1 Health Maintenance
- Section 2.2 Cardiovascular Health
- Section 2.3 Metabolic and Nutritional Health
- Section 2.4 Urinary Tract Assessment
- Section 2.5 Contraception and Reproductive Health
- Section 2.6 Infectious Diseases
- Section 2.7 Cancer Screening and Prevention
- Section 2.8 Neurologic, Behavioral, and Psychosocial Health
- Section 2.9 Pregnancy
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- The Well-Woman Visit , pp. 171 - 180Publisher: Cambridge University PressPrint publication year: 2017
References
Guidelines
Moyer, V.A. Screening for chronic kidney disease: US Preventive Services Task Force recommendation statement. US Preventive Services Task Force. Ann Intern Med. 2012, 157:567–70.Google ScholarPubMed
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39:S1–266.Google Scholar
Qaseem, A., Hopkins, R.H., Sweet, D.E., Starkey, M., and Shekelle, P. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians. Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2013, 159:835–47.Google Scholar
ASN disagrees with new guidelines, says adults should be screened for kidney disease [press release]. Nephrol News Issues [electronic], 2013. Available at: www.nephrologynews.com/articles/109817-asn-disagrees-with-new-guidelines-says-adults-should-be-screened-for-kidney-disease. Retrieved December 23, 2015.Google Scholar
References
United States Renal Data System. Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2014.Google Scholar
Meguid, A., El Nahas, B., and Aminu, K. Chronic kidney disease: The global challenge. Lancet. 2005, 365(9456):331–40.Google Scholar
Fink, H.A., Ishani, A., Taylor, B.C. et al. Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment. Comparative Effectiveness Review 37. AHRQ Publication 11(12)-EHC075-EF. Rockville, MD: Agency for Healthcare Research and Quality, 2012.Google ScholarPubMed
Fink, H.A., Ishani, A., Taylor, B.C. et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: A systematic review for the US Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2012, 156:570–81.Google Scholar
Ward, F., Holian, J., and Murray, P. Drug therapies to delay the progression of chronic kidney disease. Clin Med. 2015, 15(6):550–7.Google Scholar
Sato, K., Hayashi, T., Uehara, S. et al. Drinking pattern and risk of chronic kidney disease: The Kansai Healthcare Study. Am J Nephrol. 2014, 40(6):516–22.CrossRefGoogle ScholarPubMed
Wang, H., Hsu, Y.H., Chuang, S.Y. et al. Use of nonsteroidal anti-inflammatory drugs and risk of chronic kidney disease in subjects with hypertension: Nationwide Longitudinal Cohort Study. Hypertension. 2015, 66(3):524–33.Google Scholar
Rovin, B. and Parikh, S. Lupus nephritis: The evolving role of novel therapeutics. Am J Kidney Dis. 2014, 63(4):677–90.CrossRefGoogle ScholarPubMed
Guidelines
Conry, J.A. and Brown, H. Well-Woman Task Force: Components of the Well-Woman Visit. Obstet Gynecol. 2015, 126(4):697–701.CrossRefGoogle ScholarPubMed
Colgan, R., Nicolle, L.E., McGlone, A., and Hooton, T.M. Asymptomatic bacteriuria in adults. Am Fam Physician. September 15, 2006, 74(6):985–90. Available online at: www.aafp.org/afp/2006/0915/p985.html.Google Scholar
Nicolle, L.E., Bradley, S., Colgan, R. et al. Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infec Dis. 2005, 40(5):643–54. Available at: http://cid.oxfordjournals.org/content/40/5/643.full#ref-50.CrossRefGoogle Scholar
Guidelines for Perinatal Care. American Academy of Pediatrics [and] the American College of Obstetricians and Gynecologists. 7th ed. Perinatal care. March 2013. Available at: www.acog.org/Resources-And-Publications/Guidelines-for-Perinatal-Care.Google Scholar
Clinical Summary: Asymptomatic Bacteriuria in Adults: Screening. US Preventive Services Task Force. October 2014. Available at: www.uspreventiveservicestaskforce.org/Page/Document/ClinicalSummaryFinal/asymptomatic-bacteriuria-in-adults-screening.Google Scholar
References
Nicolle, L.E. Asymptomatic bacteriuria: When to screen and when to treat. Infect Dis Clin North Am. 2003, 17:367–94.Google Scholar
Bengtsson, C., Bengtsson, U., Bjorkelund, C., Lincoln, K.M., and Sigurdson, J.A. Bacteriuria in a population sample of women: 24-year follow-up study. Results from the prospective population-based study of women in Gottenburg, Sweden. Scand J Urol Nephrol. 1998, 32:284–9.Google Scholar
Cai, T., Nesi, G., Mazzoli, S. et al. Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections. Clin Infect Dis. December 1, 2015, 61(11):1655–61. Epub August 12, 2015.Google Scholar
Zalmanovici Trestioreanu, A., Lador, A., Sauerbrun-Cutler, M.T., and Leibovici, L. Antibiotics for asymptomatic bacteriuria. Cochrane Database Syst Rev. April 8, 2015.CrossRefGoogle Scholar
Geerlings, S.E., Stolk, R.P., Camps, M.J. et al. Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med. 2001, 161:1421–7.CrossRefGoogle ScholarPubMed
Waites, K.B., Canupp, K.C., and DeVivo, M.J. Eradication of urinary tract infection following spinal cord injury. Paraplegia. 1993, 31:645–52.Google ScholarPubMed
Warren, J.W., Anthony, W.C., Hoopes, J.M., and Muncie, H.L. Jr. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA. 1982, 248:454–8.CrossRefGoogle ScholarPubMed
Guidelines
American College of Obstetricians and Gynecologists. Well-woman Recommendations. Washington, DC: American College of Obstetricians and Gynecologists, 2015. Available at: //www.acog.org/About-ACOG/ACOG-Departments/Annual-Womens-Health-Care/Well-Woman-Recommendations. Retrieved March 12, 2015.Google Scholar
World Health Organization. Age-Friendly Primary Health Care Centres Toolkit. Geneva: WHO, 2008. Available at: www.who.int/ageing/publications/upcoming_publications/en/. Retrieved May 17, 2016.Google Scholar
Centers for Disease Control and Prevention. Knowledge, attitudes, and practices of physicians regarding urinary incontinence in persons aged > or = 65 years – Massachusetts and Oklahoma, 1993. MMWR Morb Mortal Wkly Rep. 1995, 44(747):753–4.+or+=+65+years+–+Massachusetts+and+Oklahoma,+1993.+MMWR+Morb+Mortal+Wkly+Rep.+1995,+44(747):753–4.>Google Scholar
Centers for Medicare and Medicaid Services. Physician Quality Reporting System (PQRS): Measures List. Baltimore, MD: CMS, 2016. Available at: www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/PQRS/MeasuresCodes.html. Retrieved May 17, 2016.Google Scholar
References
Wu, J., Vaugh, C., Goode, P. et al. Prevalence and trends of symptomatic pelvic floor disorders in US women. Obstet Gynecol. 2014, 123:141–8.CrossRefGoogle Scholar
American College of Obstetricians and Gynecologists. Urinary Incontinence in Women. Practice Bulletin No. 155. Obstet Gynecol. 2015, 126:e66–81.Google Scholar
Brown, J., Bradley, C., Subak, L. et al. The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med. 2006, 144:715–23.Google Scholar
Grarely, A. and Noor, N. Diagnosis and surgical treatment of stress urinary incontinence. Obstet Gynecol. 2014, 124:1011–27.Google Scholar